Post by Johnson & Johnson Innovative Medicine UK

We were delighted to be part of this year’s American Society of Clinical Oncology (ASCO) Annual Conference 2026, where the global oncology community came together to share the latest advances shaping the future of cancer care. As the oncology landscape continues to evolve, meetings such as ASCO play a vital role in bringing experts together to exchange insights and advance innovation. At J&J, we remain committed to working in collaboration with partners across the health system to help improve outcomes for people living with cancer. Thank you to all colleagues, healthcare professionals, researchers and partners who connected with us during the meeting. We look forward to continuing these important conversations. CP-583654 | June 2026